Bristol-Myers Squibb Co
BRM
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Contact
Route 206 and Province Line Road
Princeton
New JerseyNJ08543
USAT: +1 609 252-4621
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
34,100
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,179.30 | 54.10 | 0.67% |
| CAC 40 | 7,482.36 | 155.89 | 2.13% |
| DAX 40 | 21,961.97 | 668.44 | 3.14% |
| Dow JONES (US) | 39,606.57 | 419.59 | 1.07% |
| FTSE 100 | 8,403.18 | 74.58 | 0.90% |
| HKSE | 22,013.48 | 59.14 | -0.27% |
| NASDAQ | 16,708.05 | 407.63 | 2.50% |
| Nikkei 225 | 35,244.41 | 375.78 | 1.08% |
| NZX 50 Index | 12,042.84 | 86.37 | 0.72% |
| S&P 500 | 5,375.86 | 88.10 | 1.67% |
| S&P/ASX 200 | 7,972.30 | 51.80 | 0.65% |
| SSE Composite Index | 3,310.40 | 14.04 | 0.43% |